CGM and Intermittent Fasting: Glucose Data During 16:8 and OMAD
How intermittent fasting affects blood sugar — CGM data shows fasting glucose drops 5-15 mg/dL during 16:8 windows, plus dawn phenomenon and refeeding patterns.
What Happens to Blood Sugar During Fasting?
When you stop eating, blood glucose gradually decreases as cells continue to absorb glucose from the bloodstream. Within 4 to 6 hours after your last meal, postprandial glucose has returned to baseline (typically 75-95 mg/dL for healthy individuals). As the fast extends beyond 8 to 12 hours, insulin levels drop significantly, and the body begins shifting from glucose-burning to fat-burning as its primary fuel source — a metabolic transition that is central to the proposed health benefits of intermittent fasting. A continuous glucose monitor reveals this transition in real time. During the first 12 hours, glucose typically stabilizes at 75 to 90 mg/dL. Between 12 and 24 hours, many people observe a gradual decline to 70 to 85 mg/dL as liver glycogen stores are progressively depleted. Some fasters experience a paradoxical glucose rise in the early morning hours (the dawn phenomenon) caused by cortisol-driven hepatic glucose production — this is a normal physiological response visible on CGM even without eating.
How CGM Optimizes Your Fasting Protocol
Intermittent fasting comes in many protocols: 16:8 (16 hours fasting, 8 hours eating), 18:6, 20:4 (OMAD — one meal a day), and 5:2 (5 normal days, 2 reduced-calorie days). CGM data helps identify which protocol works best for your body. The 16:8 protocol is the most popular starting point. CGM data typically shows that glucose stabilizes at its lowest and most stable levels between hours 12 and 16, suggesting that extending the fast beyond 16 hours provides diminishing metabolic returns for most people. However, some individuals observe that their fasting glucose remains elevated (above 95 mg/dL) even after 16 hours, which may indicate that a longer fasting window or dietary changes during the eating window are needed. The optimal eating window can also be identified through CGM: if your glucose response to an identical meal is significantly lower at lunch than at dinner, this suggests that eating your largest meal earlier in the day aligns better with your circadian insulin sensitivity — a finding supported by research in Cell Metabolism showing that morning eating produces 15% lower glucose responses than evening eating.
Breaking the Fast: What CGM Shows
How you break your fast has an outsized effect on glucose stability for the rest of the day. CGM data consistently shows that breaking a 16-hour fast with a high-glycemic meal (e.g., pancakes, toast with jam, fruit juice) produces a glucose spike that is 30 to 50% larger than eating the same meal after a normal overnight fast. This occurs because prolonged fasting temporarily reduces the body's insulin secretion capacity — after hours of low insulin demand, the first carbohydrate load catches the system underprepared. CGM users learn that the optimal fast-breaking meal is moderate in carbohydrates, includes protein and fat, and is eaten slowly. A common pattern discovered through CGM: breaking a fast with eggs, avocado, and a small serving of berries produces a glucose rise of 15 to 25 mg/dL, while a bowl of oatmeal with honey produces a 50 to 70 mg/dL spike. These insights are invisible without continuous glucose monitoring and often contradict generic nutrition advice about "healthy" breakfast foods.
Fasting, CGM, and Metabolic Health Goals
Intermittent fasting combined with CGM monitoring supports several metabolic health goals. For weight loss, CGM data confirms that fasting windows reduce overall insulin exposure (lower insulin = enhanced fat oxidation) and helps ensure that eating windows are not undermining the fast through excessive glucose spikes. For metabolic health improvement, tracking fasting glucose trends over weeks reveals whether insulin sensitivity is improving — a declining fasting glucose from 98 mg/dL to 88 mg/dL over 6 weeks suggests meaningful metabolic improvement. For longevity-focused biohackers, minimizing time above 140 mg/dL and reducing glucose variability are the primary CGM-derived targets. A 2022 study in Cell Reports Medicine found that time-restricted eating (a form of intermittent fasting) combined with CGM monitoring reduced average glucose by 5 mg/dL, improved glucose variability by 12%, and decreased fasting insulin by 15% over 12 weeks in healthy adults. These are meaningful improvements for long-term metabolic health, even though they may not appear on standard A1C or fasting glucose blood tests.